Table 1.
Mouse Model | Route | Asymptomatic Infection | Neurologic Signs | Hematological Changes | Disease Signs | Pro-Inflammatory Cytokines | Ref. |
---|---|---|---|---|---|---|---|
BALB/c | IP, I.C. | NR | Yes | Yes | NR | [74] | |
A/J | IV | NR | Yes | Transient thrombocytopenia | NR | NR | [71] |
IV | Yes | Yes | Transient ↑ hematocrit and ↓ WBC count | NR | NR | [90] | |
IV | NR | Yes | Hematocrit: Slight ↑ | NR | NR | [91] | |
IV | NR | NR | NR | Vascular permeability: High | NR | [92] | |
IV | NR | Yes | NR | Yes | IFN-γ: ↑ | [93] | |
IP | NR | NR | NR | Yes | IFN-γ, IL-6, IL-12, TNF-α: ↑ | [94] | |
IP | Yes | Yes | ↑ levels of transaminases | Vascular leakage: High | IFN-γ, IL-6 and TNF-α: ↑ | [77,95] | |
IP | Yes | Yes | Early leukopenia | Yes | IL-1α, IL-6, IL-12p40, IL-17A, IFN-γ and TNF-α: ↑ | [96] | |
IP | NR | NR | Thrombocytopenia | Plasma leakage | IL-2, IL-4, and TNFα: ↑ | [97] | |
IP | NR | NR | Coagulopathy | Plasma leakage | IL-2, IL-4, and TNFα: ↑ | ||
IP | NR | NR | Thrombocytopenia | Plasma leakage | IL-1α, IL-6, IL-10, IL-12p40, IFN-γ and G-CSF: ↑ | [80] | |
IP | NR | Yes | Leukopenia Thrombocytopenia | Yes | IL-1α, IL-6, IL-10, IL-12p40, IFN-γ, and G-CSF: ↑ | [98] | |
A129 | IV | NR | Yes | NR | Yes | IFN-γ: ↑ | [93] |
IV | NR | Yes | NR | Yes | TNF-α and IL-10: ↑ | [99] | |
IV | NR | NR | Thrombocytopenia and Lymphopenia: Moderate AST: Elevated | Severe liver damage Vascular leakage Middle | DENV-2: IL-6: ↑ | [100] | |
IFNAR−/− | IV | NR | Yes | NR | NR | TNF-α and IL-10: ↑ | [99] |
IV | NR | NR | NR | Yes | NR | [52] | |
IP | NR | NR | NR | Yes | IL-6, INF-α, IP10, IFN-a, IFN-γ: ↑ | [101] | |
Cardif−/− C57BL/6 | IV | Yes | NR | NR | NR | IFN-α: ↑ | [102] |
STAT1−/− | IV | NR | NR | NR | NR | IFNα: ↓ IFNβ: ↑ | [81] |
IC | NR | Yes | NR | Yes | NR | [103] | |
STAT2−/− | IV | NR | NR | NR | IFNα: ↓ IFNβ: ↑ | [81] | |
STAT1−/− STAT2−/−and STAT1−/− IFNAR−/− | IV | NR | NR | NR | NR | IFNα: ↓ IFNβ: ↑ |
Route of inoculation: intravenous (IV), intraperitoneal (IP), intracardiac (IC), intraperitoneal (IP), intracranial (I.C.). Clinical description (presence of some of these signs). Neurologic signs: incoordination, loss of balance, kyphoscoliosis, and partial paralysis of posterior limbs, posture instability, ataxia, involuntary contractions, spasmodic movements, and limb paralysis. Disease signs: fur ruffling, weight loss, hunchback posture, abdominal distention, diarrhea-like, limited mobility, intestinal hemorrhage at 8 days after infection, erythema, increased temperature or fever. Thrombocytopenia: changes in platelets count comparing each mouse model with control group. Proinflammatory cytokines: change in cytokines levels compared with control group. Increase: (↑), decrease: (↓). NR: not reported.